About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

Active Not RecruitingNCT05267509

An Integrated Radio-immunological Approach

The most aggressive primary brain tumors in adults, glioblastomas, are characterized by a profound local and systemic immune suppression. During tumor progression, the infiltration of inflammatory leu...

Lead sponsor: Istituto Oncologico Veneto IRCCS•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Istituto Oncologico Veneto IRCCS

Collaborators

Azienda Ospedaliero-Universitaria Careggi
Azienda Ospedaliera di Padova

Age

18 - 80 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•All patients with histologic confirmation of malignant glioma
•Patients must be age \>= 18 years
•Patients must be able to obtain an MRI scan with gadolinium contrast
•Patients must sign informed consent indicating that they are aware of the investigational nature of this study:

Related studies

RECRUITINGEARLY Phase 1

Window of Opportunity Study of DSP-0390 in Gliomas

NCT06636162 · Glioma, Malignant, IDH Mutation

Efficacy of a Mixed Distancial Neuropsychological Rehabilitation Program in Patients With Grade 2 or 3 Diffuse Glioma

NCT06468176 · Glioma, Malignant

RECRUITINGPhase 2

FET PET in Differentiating Tumour Progression From Pseudoprogression in High Grade Glioma

NCT06172595 · Glioma, Malignant

RECRUITINGPhase 1

Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant Glioma

NCT06585527 · Glioblastoma Multiforme, Glioma, Malignant

Active Not RecruitingEARLY Phase 1

AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients

NCT05182905 · Glioblastoma, Glioma, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 23, 2026Terms

Trial snapshot

StatusACTIVE_NOT_RECRUITING

Phase—

Enrollment31

Start dateFeb 2022

Last updatedJan 23, 2026

Condition

Glioma, Malignant

Locations shown

University Hospital

Florence

University Hospital

Padua

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 23, 2026Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions